A synthetic 15-amino-acid peptide extensively investigated in preclinical models involving cellular protection, vascular signalling and tissue-repair biology. Despite considerable experimental interest, human clinical evidence remains limited and no approved therapeutic formulation exists.
| Title |
|---|
| 4 vials (15% discount) |
| 8 vials (25% discount) |
| 12 vials (35% disocunt) |
(Body Protection Compound-157) is a synthetic 15-amino-acid peptide derived from a sequence associated with a protein found in gastric juice. It has been extensively investigated in preclinical research for its potential involvement in tissue protection, cellular repair and inflammatory regulation.
BPC-157 has been studied in experimental models examining tendon, ligament, muscle and gastrointestinal tissue repair. Research suggests that it interacts with several biological pathways associated with angiogenesis, fibroblast activity, nitric oxide signaling and cellular protection. These mechanisms have generated scientific interest in its potential role in tissue regeneration.
BPC-157 10 mg is presented as an experimental research peptide for laboratory and scientific applications. The stated quantity refers to the amount of peptide contained in the product and should not be interpreted as a recommended human dosage.
Product: BPC-157
Strength: 10 mg
Alternative name: Body Protection Compound-157
Category: Recovery
Compound classification: Synthetic pentadecapeptide
Research target: Tissue repair-associated pathways, including VEGF-related signaling and nitric oxide regulation
Research focus: Tendon and ligament biology, muscle tissue repair, gastrointestinal protection and inflammatory signaling
Mechanism: Investigated for its modulation of angiogenesis, fibroblast activity, nitric oxide signaling and cellular repair pathways
Pharmacological profile: Experimental tissue-protective peptide with predominantly preclinical evidence and limited human safety data
Intended use: Laboratory and research use only
WOLVERINE is a multi-peptide research formulation of BPC-157 and TB-500. These peptides are individually investigated for their involvement in tissue repair, cellular migration, inflammatory signaling and extracellular matrix remodeling.
Associated with Thymosin Beta-4, a naturally occurring peptide involved in tissue repair, wound healing and cellular regeneration. Research explores its role in cell migration, blood vessel formation (angiogenesis), inflammatory regulation and tissue remodeling, including recovery in muscle, tendon, skin and cardiovascular tissue.
A tripeptide corresponding to the C-terminal sequence Lys-Pro-Val associated with ฮฑ-MSH biology. Research interest centres on cellular signalling involved in inflammatory and immune-regulatory processes.
A combined formulation intended for studying multiple signalling components within one experimental system, BPC-157 + TB-500 + GHK-Cu + KPV blend.
A multi-component research formulation combining peptides associated with cellular repair, extracellular-matrix signalling and tissue-remodelling research. The final page should identify every component and its exact amount rather than marketing GLOW as a single molecular entity.
A synthetic peptide derived from the helix-B region of erythropoietin (EPO), investigated for tissue-protective signalling without reproducing EPOโs erythropoietic activity. Its research landscape includes inflammatory regulation, cellular protection and tissue-repair signalling pathways.